array:24 [
  "pii" => "S0213911104720385"
  "issn" => "02139111"
  "doi" => "10.1016/S0213-9111(04)72038-5"
  "estado" => "S300"
  "fechaPublicacion" => "2004-11-01"
  "aid" => "72038"
  "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
  "copyrightAnyo" => "2004"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Gac Sanit. 2004;18:486"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3419
    "formatos" => array:3 [
      "EPUB" => 107
      "HTML" => 2429
      "PDF" => 883
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0213911104720397"
    "issn" => "02139111"
    "doi" => "10.1016/S0213-9111(04)72039-7"
    "estado" => "S300"
    "fechaPublicacion" => "2004-11-01"
    "aid" => "72039"
    "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Gac Sanit. 2004;18:487-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4924
      "formatos" => array:3 [
        "EPUB" => 108
        "HTML" => 3830
        "PDF" => 986
      ]
    ]
    "es" => array:7 [
      "idiomaDefecto" => true
      "titulo" => "Réplica"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "487"
          "paginaFinal" => "488"
        ]
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "José A. Sacristán, Luis Prieto, Teresa Huete, Antonio Artigas, Xavier Badía"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "José A."
              "apellidos" => "Sacristán"
            ]
            1 => array:2 [
              "nombre" => "Luis"
              "apellidos" => "Prieto"
            ]
            2 => array:2 [
              "nombre" => "Teresa"
              "apellidos" => "Huete"
            ]
            3 => array:2 [
              "nombre" => "Antonio"
              "apellidos" => "Artigas"
            ]
            4 => array:2 [
              "nombre" => "Xavier"
              "apellidos" => "Badía"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911104720397?idApp=WGSE"
    "url" => "/02139111/0000001800000006/v1_201310251459/S0213911104720397/v1_201310251459/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0213911104720373"
    "issn" => "02139111"
    "doi" => "10.1016/S0213-9111(04)72037-3"
    "estado" => "S300"
    "fechaPublicacion" => "2004-11-01"
    "aid" => "72037"
    "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Gac Sanit. 2004;18:483-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 4596
      "formatos" => array:3 [
        "EPUB" => 521
        "HTML" => 2815
        "PDF" => 1260
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "La Unidad de Atención Crohn-Colitis: 3 años de actividad"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "483"
          "paginaFinal" => "485"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "The Crohn-Colitis Care unit: analysis of the first 3 years of activity"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Gisel Fontanet, Francesc Casellas, Juan Ramón Malagelada"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Gisel"
              "apellidos" => "Fontanet"
            ]
            1 => array:2 [
              "nombre" => "Francesc"
              "apellidos" => "Casellas"
            ]
            2 => array:2 [
              "nombre" => "Juan"
              "apellidos" => "Ramón Malagelada"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911104720373?idApp=WGSE"
    "url" => "/02139111/0000001800000006/v1_201310251459/S0213911104720373/v1_201310251459/es/main.assets"
  ]
  "es" => array:8 [
    "idiomaDefecto" => true
    "titulo" => "Cuidado con las Evaluaciones Económicas!"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "486"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Oriol de Solà-Morales, Joan M.V. Pons"
        "autores" => array:2 [
          0 => array:2 [
            "nombre" => "Oriol"
            "apellidos" => "de Solà-Morales"
          ]
          1 => array:2 [
            "nombre" => "Joan M.V."
            "apellidos" => "Pons"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Agència d'Avaluació de Tecnologies i Recerca Mèdiques (AATRM). Barcelona. España"
          ]
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "Bibliogrífia"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:7 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Coste-efectividad de drotrecogina alfa (activada) en el tratamiento de la sepsis grave en España"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J.A. Sacristan"
                            1 => "L. Prieto"
                            2 => "T. Huete"
                            3 => "A. Artigas"
                            4 => "X. Badia"
                            5 => "C. Chinn"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Gac Sanit"
                        "fecha" => "2004"
                        "volumen" => "18"
                        "paginaInicial" => "50"
                        "paginaFinal" => "57"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14980173"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risks and benefits of activated protein C treatment for severe sepsis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "H.S. Warren"
                            1 => "A.F. Suffredini"
                            2 => "P.Q. Eichacker"
                            3 => "R.S. Munford"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMsb020574"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2002"
                        "volumen" => "347"
                        "paginaInicial" => "1027"
                        "paginaFinal" => "1030"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12324562"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "P.Q. Eichacker"
                            1 => "C. Natanson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/01.CCM.0000042473.84847.EA"
                      "Revista" => array:7 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2003"
                        "volumen" => "31"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "S94"
                        "paginaFinal" => "S96"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12544982"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Benefit of recombinant human activated protein C beyond 28-day mortality: there is more to life than death"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "M. Levi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/01.CCM.0000055386.01914.0C"
                      "Revista" => array:6 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2003"
                        "volumen" => "31"
                        "paginaInicial" => "984"
                        "paginaFinal" => "985"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12627023"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E.W. Ely"
                            1 => "P.F. Laterre"
                            2 => "D.C. Angus"
                            3 => "J.D. Helterbrand"
                            4 => "H. Levy"
                            5 => "J.F. Dhainaut"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/01.CCM.0000046070.25223.79"
                      "Revista" => array:6 [
                        "tituloSerie" => "Crit Care Med"
                        "fecha" => "2003"
                        "volumen" => "31"
                        "paginaInicial" => "12"
                        "paginaFinal" => "19"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12544987"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pons JMV. Avaluació de l'evidència científica de l'ús de la proteïna C activada recombinant-drotrecogin alfa (activat) - en la sèpsia greu"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "O. De Solà-Morales"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:1 [
                        "serieFecha" => "2004"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7."
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The effect of Drotrecogin alfa (activated) on long-term survival after severe sepsis. Chest 2002 Scientific Highlights. Abstracts of original investigations and case reports. 2-7 November 2002, San Diego, California"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "D.C. Angus"
                            1 => "P.F. Laterre"
                            2 => "J.D. Helterbrand"
                            3 => "D. Ball"
                            4 => "R.K. Garg"
                            5 => "R. Gordon"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Chest"
                        "fecha" => "2002"
                        "volumen" => "122"
                        "numero" => "Suppl 4"
                        "paginaInicial" => "S51"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02139111/0000001800000006/v1_201310251459/S0213911104720385/v1_201310251459/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "677"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Cartas al Director"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02139111/0000001800000006/v1_201310251459/S0213911104720385/v1_201310251459/es/main.pdf?idApp=WGSE&text.app=https://gacetasanitaria.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911104720385?idApp=WGSE"
]
Compartir
Publique en esta revista
Información de la revista
Vol. 18. Núm. 6.
Páginas 486 (noviembre - diciembre 2004)
Respuestas rápidas
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 18. Núm. 6.
Páginas 486 (noviembre - diciembre 2004)
Open Access
Cuidado con las Evaluaciones Económicas!
Visitas
6239
Oriol de Solà-Morales, Joan M.V. Pons
Agència d'Avaluació de Tecnologies i Recerca Mèdiques (AATRM). Barcelona. España
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
El Texto completo está disponible en PDF
Bibliogrífia
[1.]
J.A. Sacristan, L. Prieto, T. Huete, A. Artigas, X. Badia, C. Chinn, et al.
Coste-efectividad de drotrecogina alfa (activada) en el tratamiento de la sepsis grave en España.
Gac Sanit, 18 (2004), pp. 50-57
[2.]
H.S. Warren, A.F. Suffredini, P.Q. Eichacker, R.S. Munford.
Risks and benefits of activated protein C treatment for severe sepsis.
N Engl J Med, 347 (2002), pp. 1027-1030
[3.]
P.Q. Eichacker, C. Natanson.
Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials.
Crit Care Med, 31 (2003), pp. S94-S96
[4.]
M. Levi.
Benefit of recombinant human activated protein C beyond 28-day mortality: there is more to life than death.
Crit Care Med, 31 (2003), pp. 984-985
[5.]
E.W. Ely, P.F. Laterre, D.C. Angus, J.D. Helterbrand, H. Levy, J.F. Dhainaut, et al.
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis.
[6.]
O. De Solà-Morales.
Pons JMV. Avaluació de l'evidència científica de l'ús de la proteïna C activada recombinant-drotrecogin alfa (activat) - en la sèpsia greu.
[7.]
D.C. Angus, P.F. Laterre, J.D. Helterbrand, D. Ball, R.K. Garg, R. Gordon.
The effect of Drotrecogin alfa (activated) on long-term survival after severe sepsis. Chest 2002 Scientific Highlights. Abstracts of original investigations and case reports. 2-7 November 2002, San Diego, California.
Chest, 122 (2002), pp. S51
Copyright © 2004. Sociedad Española de Salud Pública y Administración Sanitaria
Descargar PDF
Idiomas
Gaceta Sanitaria
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?